[Transrectal hyperthermia in the treatment of benign prostatic hyperplasia].
X Wang, S. Hou, Zhu J
Abstract
X Wang, S. Hou, Zhu J
Abstract
A group of 53 patients with benign prostatic hyperplasia underwent transrectal hyperthermia using Prostathermer (Biodan) from September 1992 to March 1993. 41 of the 53 patients were followed up for 6 months. The subjective symptoms improved in 75.6% (31/41) of the treated patients. The mean maximum urine flow rate increased by 3.1 +/- 2.6 ml/s. The mean residual urine reduced 38.4 +/- 25.2 ml. The mean prostate volume remained almost unchanged. The results showed that transrectal hyperthermia of the prostate gland is as effective as transurethral approach for the treatment of benign prostatic hyperplasia.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A group of 53 patients with benign prostatic hyperplasia underwent transrectal hyperthermia using Prostathermer (Biodan) from September 1992 to March 1993. 41 of the 53 patients were followed up for 6 months. The subjective symptoms improved in 75.6% (31/41) of the treated patients. The mean maximum urine flow rate increased by 3.1 +/- 2.6 ml/s. The mean residual urine reduced 38.4 +/- 25.2 ml. The mean prostate volume remained almost unchanged. The results showed that transrectal hyperthermia of the prostate gland is as effective as transurethral approach for the treatment of benign prostatic hyperplasia.
Key concepts: Medicine, Hyperplasia, Hyperthermia, Urology, Prostate, Urine flow rate, Residual urine, Adenoma